Study of medullary thyroid cancer progression in a registry
Part of Cancer clinical trials.
This study follows people with medullary thyroid cancer to better understand how the disease changes over time, including in advanced stages. You may help improve future treatment planning and care for people with medullary thyroid cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with medullary thyroid cancer
- You are enrolled (registered) in the Medullary Thyroid Cancer Registry (MTCR)
- For part of the study, your cancer is considered advanced (red or gray stage) based on the study team’s review
- For the advanced part, you must also be a current MTCR registrant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial follows people with medullary thyroid cancer to better understand their experiences. You may join if you have this diagnosis, are 18 or older, and are not taking another experimental drug.
This study follows adults who have medullary thyroid cancer (MTC) to learn how the cancer behaves over time. It may help by improving future care and follow-up strategies for people with MTC.
This study follows children and adults with medullary thyroid cancer (MTC) and/or MEN2 to better understand how the condition progresses over time. It may help doctors plan care in the future by collecting long-term health and lab information, not by giving a new treatment.
This study collects real-world information from patients with advanced thyroid cancer to better understand how standard treatments and specialized procedures work. Your participation will help improve care for others with this type of cancer.
This study is a registry that collects information about adults with certain types of thyroid cancer. It may help researchers learn more about these cancers and how people are doing over time.
This study looks at a small blood test (called ctDNA) and tumor tissue to understand how advanced thyroid cancers change over time. It may help doctors better monitor cancer growth and guide treatment choices.
Hear when a new Advanced Thyroid Gland Medullary Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.